Publication of the first joint transnational call of the EUP OH AMR (European Partnership on One Health Antimicrobial Resistance): 'Treatments and adherence to treatment protocols (OH-TREAT)'

On 18 November 2025, the Ministry of Health (hereinafter referred to as the "MZD") publishes the following information in accordance with Act No. 130/2002 Coll., on support for research, experimental development and innovation from public funds and on amendments to certain related acts (Act on support for research, experimental development and innovation), as amended (hereinafter referred to as the "Act"),

EUP OH AMR (European Partnerhsip on One Health Antimicrobial Resistance): Treatments and adherence to treatment protocols ("OH-TREAT")

Call 2026

Deadline for announcement of results
November 2026

National budget allocation for the call
500 000 EUR

Maximum amount of support per project
250 000 EUR

Maximum aid intensity per project
Table: Maximum possible aid intensity by type of entity and type of research (according to the current version Methodology: European Partnerships in Health)

Applicants
research organisation, enterprise, patient organisations

Project duration
3years / 36 months

Deadlines for submission of project proposals:
Pre-proposals: 2 February 2026, 13:00 CET
Full proposals: 17 June 2026, 13:00 CEST

Interested parties can participate in the international information webinar on 26 November 2025. Registration is available at this link: REGISTER

Documents

Conditions for the participation of the Czech candidate in the AMR 2026 Olympic Games

Methodology: European Partnerships for Health

Sub-programme 3: European Partnerships in Health - effective from 22.5.2024

Mandatory attachments of the Czech applicant for Phase 1 (pre-proposals)

  1. Affidavit on behalf of the tenderer or co-tenderer (PO)
  2. Affidavit on behalf of the tenderer or co-tenderer (FO)
  3. Affidavit for research organisations (if applicable)
  4. Affidavit of consortium composition (only if a Czech company is represented in the project)
  5. Budget tableAZV ČR Application Form)

Mandatory annexes of the Czech applicant for Phase 2 (full proposals)

  1. Affidavit of competence;
  2. Updated budget table AZV ČR Application Form)

Other documents

Commission Regulation

Frascati manual

Definition of types of results

The official call documents are available here

Information about the call

The first joint transnational call of the EUP OH AMR Partnership: 'Treatments and adherence to treatment protocols (OH-TREAT)'aims to:

  • development of new treatment protocols or alternative strategies for infectious diseases;
  • improve, maintain and enhance the clinical efficacy of concomitant antimicrobial products;
  • The need to identify barriers that prevent end users from properly adhering to established treatment protocols.
  • Improve the success rate of treatment of bacterial and fungal infections in humans, animals and plants. This is to be achieved by developing new treatment options, while reducing the risk of emergence and spread of resistance within the One Health concept.

Projects must address one of the following three themes: 

  • Theme 1: Identify and develop new combination therapeutic approaches that use existing or new antimicrobial agents or their combination with complementary therapies. These approaches should prolong the effectiveness of drugs and reduce the development of resistance.
  • Theme 2: Develop tools and methods to improve adherence to treatment. 
  • Theme 3: Assess the impact of antimicrobial use in veterinary and agricultural practice on the risk of transmission of antimicrobial resistance to humans and the environment, with the aim of informing policy development to limit the use of certain antimicrobials in humans.

Warning!: Czech applicants can participate in all three themes listed above. However, national support is limited to human health only.

Size of the project consortium

Each project consortium must include at least 3 eligible partners applying for funding from 3 different eligible countries - at least 2 of which must be from EU Member States or associated countries. The maximum number of partners in a consortium is 6, including those not applying for funding. This number can be increased to 7. The project coordinator must be eligible for funding by its regional/national funding organisation participating in the call. The project coordinator may not be changed between the first and second phase.

List of participating countries:

Austria (FWF), Belgium (FNRS, FWO, SPW), Canada (CIHR), Czech Republic (MZCR/AZVCR), Denmark (IFP), Estonia (ETAG), Finland (AKO), France (ANR), Germany (BMFTR/DLR-PT), Hungary (NKFIH), Ireland (DAFM, TÉ-RI, HRB), ISRAEL (CSO-MOH), Italy (FRRB, MOH-IT), Latvia (LZP), Lithuania (LMT), Malta (XM), Moldova (NARD), Netherlands (NWO), Norway (RCN), Poland (NCN), Portugal (FCT), Slovakia (CVTI SR), South Africa (SAMRC), Spain (IACS, AEI, ISCIII), Sweden (SRC), Switzerland (SNSF), Turkey (TUBITAK), UK (MRC-UKRI/DHCS/DHCS).

*The list of participating countries is current as of 18 November 2025.

Call rules:

The call is governed by transnational rules common to applicants from all participating countries. In addition to the transnational rules, Czech applicants must also comply with the national conditions set by the relevant national provider. Applicants participating in applied research projects will therefore have to comply with national conditions based on Sub-programme 3: European Partnerships in Health.

Contact person:

Mgr. Monika Kocmanová
Email: 
Tel: +420 778 973 186

You can also submit questions about the transnational call via email: .